Trials / Conditions / Swine-origin A/H1N1 Influenza

Swine-origin A/H1N1 Influenza

8 registered clinical trials studyying Swine-origin A/H1N1 Influenza.

Status	Trial	Sponsor	Phase
Completed	A Study of the Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults NCT01089660	Sanofi Pasteur, a Sanofi Company	Phase 2
Unknown	Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month NCT01040078	Centers for Disease Control and Prevention, China	Phase 3
Completed	A Study of Different Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly NCT00952276	Sanofi	Phase 2
Completed	A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months NCT00956046	Sanofi Pasteur, a Sanofi Company	Phase 2
Completed	A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years NCT00956202	Sanofi Pasteur, a Sanofi Company	Phase 2
Completed	A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years NCT00952419	Sanofi Pasteur, a Sanofi Company	Phase 2
Completed	A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly NCT00953524	Sanofi Pasteur, a Sanofi Company	Phase 2
Completed	A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly NCT00954798	Sanofi Pasteur, a Sanofi Company	Phase 2